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Abstract
Background: Omega 3 fatty acids have been found to inhibit proliferation, induce apoptosis, and
promote differentiation in various cell types. The processes of cell survival, expansion, and
differentiation are of key importance in the regulation of hematopoiesis. We investigated the role
of omega 3 fatty acids in controlling the frequency of various myeloid progenitor cells in the bone
marrow of mice. Increased progenitor cell frequency and blocked differentiation are characteristics
of hematopoietic disorders of the myeloid lineage, such as myeloproliferative diseases and myeloid
leukemias.
Results: We found that increasing the proportion of omega 3 fatty acids relative to the proportion
of omega 6 fatty acids in the diet caused increased differentiation and reduced the frequency of
myeloid progenitor cells in the bone marrow of mice. Furthermore, this had no adverse effect on
peripheral white blood cell counts.
Conclusion: Our results indicate that omega 3 fatty acids impact hematopoietic differentiation by
reducing myeloid progenitor cell frequency in the bone marrow and promoting progenitor cell
differentiation. Further exploration of this discovery could lead to the use of omega 3 fatty acids as
a therapeutic option for patients that have various disorders of hematopoiesis.
Background
Omega 3 and omega 6 fatty acids are essential fatty acids
that must be obtained from dietary sources. Recently, the
ratio of omega 3 to omega 6 fatty acids consumed in the
diet has been studied in relevance to cardiac health[1],
neurological health[2], and cancer prevention[1].
Omega 3 fatty acids can compete with omega 6 fatty acids
for the same metabolic enzymes. Omega 3 and omega 6
fatty acids are incorporated into cell membranes either
directly or after elongation and desaturation by Δ4, Δ5,
and Δ6 and desaturases[3,4]. Omega 3 fatty acids have
greater affinity for the Δ4 and Δ6 desaturases than omega
6 fatty acids [5-7]. Dietary linoleic acid (18 carbons,
omega 6 fatty acid) is generally considered to be the major
source of tissue arachidonic acid (20 carbons, omega 6
fatty acids) although meat fat can be a direct source of ara-
chidonic acid[8]. All three major omega 3 fatty acids – α
linolenic acid (18:3), eicosapentaenoic acid (20:5), and
docosahexaenoic acid (22:6) – directly inhibit the produc-
tion of arachidonic acid from linoleic acid[9]. Both ara-
chidonic acid and eicosapentaenoic acid can be cleaved
from the cell membrane phospholipid stores by phos-
pholipase A2 and acted on by cyclooxygenases (either the
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constitutive COX1 or the inducible COX2) to produce
prostaglandin precursors which are isomerized by pros-
taglandin synthases to produce prostaglandins. In this
manner, COX converts arachidonic acid to form the 2-
series prostaglandins that tend to be pro-proliferative and
pro-inflammatory in most tissues[10]. Micromolar con-
centrations of prostaglandin E2 (PGE2) increase human
myeloid progenitor cell proliferation[11]. However, COX
activity on eicosapentaenoic acid forms the 3 series pros-
taglandins that tend to have anti-proliferative and anti-
inflammatory properties[10]. In addition to prostagland-
ins, leukotrienes and eicosanoids are formed from fatty
acids through activity of various lipoxygenases. These
have been shown to have varying and sometimes contro-
versial effects on either hematopoietic stem cell or mye-
loid progenitor cell differentiation[11,12]. Thus, a model
system approach is needed to effectively dissect the net
effect of dietary fatty acids on hematopoiesis in vivo.
Abnormal hematopoiesis often involves expansion of
immature cells of the myeloid lineage. In these cases, pro-
genitor cell frequency could be expanded by increased
proliferation, decreased apoptosis, or both. If omega 3
fatty acids inhibit proliferation or induce apoptosis in
myeloid progenitor cells, they could alleviate the cellular
expansion that occurs in certain disorders of hematopoie-
sis. Another characteristic of these disorders is a block in
differentiation. During normal hematopoiesis, a contin-
uum of differentiation exists, such that long term hemat-
opoietic stem cells progressively differentiate to produce
terminally differentiated cells of the blood. Since omega 3
fatty acids have been shown to promote differentiation
[11], they may serve as a therapeutic tool [13-16] for dis-
orders involving the inhibition of normal differentiation.
Our results indicate that the frequency of myeloid progen-
itors in the bone marrow of mice fed fish oil diets is two-
fold less than in those fed corn oil diets. Our data also
indicate that this reduction of progenitor cells does not
have an adverse effect on the number of circulating white
blood cells in the periphery, even after prolonged dietary
change. These results suggest a possible role for omega 3
fatty acids as therapeutic agents in disorders involving
expansion of myeloid progenitors, such as the myeloid
leukemias.
Results and discussion
High levels of omega 3 fatty acids alter the character of 
the myeloid progenitor cell compartment in the bone 
marrow
Progenitors for myeloid cells in bone marrow that can be
assessed by colony forming cell (CFC) assays include
granulocyte erythrocyte macrophage megakaryocyte
(GEMM) progenitors, granulocyte macrophage (GM) pro-
genitors, erythrocyte (E) progenitors, granulocyte (G) pro-
genitors, and macrophage (M) progenitors. Only these
progenitors have the necessary growth factors and prolif-
eration capacity to produce colonies in the CFC assay.
Morphology of these colony types are shown in Figure 1.
Mice were fed fish oil (high level omega 3 fatty acids) or
corn oil (low level omega 3 fatty acids) containing diets
(Tables 1 and 2). Mice that were fed the fish oil diet had a
significantly lower (p = 0.010) frequency of total myeloid
progenitor cells (9.78 ± 0.46 × 10-4) than those mice fed
the corn oil diet (2.10 ± 0.55 × 10-3) (Fig. 2A). These
results indicate that omega 3 fatty acids were inducing a
reduction in total myeloid progenitors in bone marrow.
GM, G, and M progenitors were significantly less (p <
0.05) frequent in the bone marrow of mice fed the fish oil
Hematopoiesis Differentiation Continuum – Myeloid Progen- itor Morphology Figure 1
Hematopoiesis Differentiation Continuum – Myeloid 
Progenitor Morphology. Hematopoiesis exists as a con-
tinuum of differentiation. Colony morphology representing 
the various myeloid progenitor cells is shown (magnification 
= 100×) in a differentiation hierarchy beginning with the least 
differentiated progenitor and continuing to the most differ-
entiated progenitor. Abbreviations: Granulocyte erythrocyte 
macrophage megakaryocyte (GEMM), granulocyte macro-
phage (GM), erythrocyte (E), granulocyte (G), macrophage 
(M).Lipids in Health and Disease 2009, 8:9 http://www.lipidworld.com/content/8/1/9
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diet than those fed the corn oil diet (Fig. 2A). Interest-
ingly, E progenitors did not change in their frequency with
diet, indicating omega 3 fatty acids preferentially affected
levels of GM progenitors and their daughter cells (see Fig.
1). There was also a larger frequency of GEMM progeni-
tors, which are early progenitors, in corn oil (5.16 ± 4.32
× 10-5) vs. fish oil (1.20 ± 1.20 × 10-5) fed mice. Although
this was a greater than 4 fold difference in frequency, the
difference was not statistically significant (p = 0.11) and
the rarity of this progenitor relative to others made it dif-
ficult to accurately assay with this technique.
Analysis of the proportions of progenitor cells that make
up the myeloid progenitor cell compartment in these
mice revealed that mice fed a fish oil diet had a much dif-
ferent proportion of early and late stage progenitors com-
pared to those fed a corn oil diet (p = 0.00015). There was
a greater percentage of later stage progenitor cells (G, M, E
progenitors) in fish oil diet fed mice (94.9 ± 1.6%) when
compared to mice fed a corn oil diet (71.3 ± 4.8%) (Fig.
2B). Conversely, there was a greater proportion of earlier
stage progenitors (GEMM and GM progenitors) in corn
oil fed mice (28.7 ± 4.8%) vs. fish oil fed mice (5.15 ±
1.6%). Thus, our data indicate that the bone marrow of
mice fed a high level of omega 3 fatty acids had a more dif-
ferentiated myeloid progenitor cell compartment than
that of mice fed a diet containing mostly omega 6 fatty
acids.
High levels of omega 3 fatty acids do not have an adverse 
effect on white blood cell production in the peripheral 
blood
To account for the concern that a lower progenitor cell fre-
quency or a greater proportion of differentiated progeni-
tor cells in the bone marrow may cause a reduction in
white blood cells in peripheral blood and therefore a
weakened immune system, we performed white blood
cell (WBC) counts on mice fed these diets from weaning
to 115 days. Results indicated no significant differences in
peripheral WBC counts in corn oil fed mice (14,825 WBC/
μl) and fish oil fed mice (13,760 WBC/μl) (Fig. 3). Thus,
fish oil diets induce a homeostatic condition of decreased
progenitor cell frequency in the myeloid compartment of
the bone marrow without adverse effects on WBC produc-
tion.
Conclusion
Our results indicate that omega 3 fatty acids reduce total
myeloid progenitor cell frequency and promote differen-
tiation of specific progenitor cell types in the bone mar-
row of mice. Furthermore, this reduction of progenitors
does not have an adverse effect on levels of circulating
white blood cells. Our data indicate that omega 3 fatty
acid effects are particular to granulocyte and macrophage
progenitor cells rather than erythrocyte maturation. The
effects of omega 3 fatty acids may occur as early in matu-
ration as the GEMM progenitor stage, and then be propa-
gated to the GM and later progenitor stages. While our
Fish oil diets cause changes in the steady state levels of mye- loid progenitors in the bone marrow Figure 2
Fish oil diets cause changes in the steady state levels 
of myeloid progenitors in the bone marrow. (A) Col-
ony forming cell (CFC) assay results of bone marrow from 
mice fed corn oil (high omega 6) vs. fish oil (high omega 3) 
diets until 60 days of age. Colonies formed represent the 
presence of a progenitor cell where the type of colony 
determines which progenitor cell type is present. Compari-
sons marked with (*) were found to be significantly different 
(p < 0.05). Error bars represent SEMs (n = 5). (B-C) Data 
from (A) where each colony type is shown as a proportion of 
total progenitor cell frequency for each diet.
Table 1: Modified AIN-76A Diet Composition.
Diet composition
Ingredient % of weight Amount/100 g
Casein (protein) 20% 20 g
Sucrose 45% 45 g
Corn starch (carbs) 15% 15 g
Alphacel (fiber) 5% 5 g
Choline bitartrate 0.2% 0.2 g
DL-methionine 0.3% 0.3 g
Mineral mix 3.5% 3.5 g
Vitamin mix 1.0% 1 g
Fat 10% 10 g
Total 100% 100 g
Total fat 10 g
Total protein 20 g
Total carbohydrate 60 g
The base diet is an AIN-76A diet modified by substitution of 5% 
sucrose for 5% more oils to contain a total of 10% w/w oil. The 
mouse food recipe contains 10% fat in each diet supplied through 
these oils.Lipids in Health and Disease 2009, 8:9 http://www.lipidworld.com/content/8/1/9
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results indicate a difference at the GM progenitor stage,
they are also suggestive, although inconclusive, of a differ-
ence at the GEMM stage. We are currently examining this
question with ongoing experiments to look at the earliest
stem and progenitor cell stages of hematopoiesis.
Examination of the effects of omega 3 fatty acids on
hematopoiesis could lead to potential therapeutic options
for patients with disorders of the blood. Future work
would include investigating the mechanisms of action for
these events. Mechanisms by which omega 3 fatty acids
have been shown to inhibit proliferation, induce apopto-
sis, and promote differentiation in many cancers include
the regulation of signaling pathways and gene expression
by peroxisome proliferator receptor activator γ(PPARγ),
for which omega 3 fatty acids are natural ligands[17].
Another mechanism of action of omega 3 fatty acids
includes inhibition of cyclooxygenase 2 (COX2), which is
upregulated in various cancers and is known to have pro-
proliferative and antiapoptotic effects [18-26]. Further-
more, the combination of activating PPARγ and
inhibition of COX2 expression has recently been shown
to inhibit proliferation and induce apoptosis in pancreatic
cancer[27]. We plan to explore these, among other mech-
anisms, using our animal model.
Regardless of the mechanisms by which omega 3 fatty
acids reduce and differentiate myeloid progenitor cells in
the bone marrow of mice, these dietary agents serve as a
promising option for therapy. The inhibitory effect of
omega 3 fatty acids on immune system function[11,28]
has led to the use of fish oils that are high in these fatty
acids in the management of several inflammatory and
autoimmune diseases[28]. Suppression of omega 6
derived eicosanoids has been proposed as a strategy for
chemoprevention and as an adjunct for treatment of can-
cer [13-16]. Our results suggest that using omega 3 fatty
acids to more rapidly differentiate myeloid progenitor
cells may slow progression of disorders of hematopoiesis,
including leukemias, and restore a more normal myeloid
progenitor cell compartment in the bone marrow.
Methods
Animals
Mice were housed in the AAALAC accredited animal facil-
ities of the Marshall Universitiy School of Medicine. All
animal use and care was approved by the Marshall Univer-
sity Institutional Animal and Use Committee. The mice
were housed 3 to 4 in a cage and individually numbered
for identification.
Table 2: Compositions of dietary fats (approximate %).
Saturated fatty acids Linoleic acid (omega 6) Total omega 3 Monounsaturated fatty acids
Corn oila 13 61 1 26
Canola oila 62 0 1 0 6 2
n-3 supp.b 96 6 3 2 1
The corn oil diet is the low omega 3: omega 6 fatty acid diet containing 10% w/w corn oil as the source of all fat. The fish oil diet is our high omega 
3: omega 6 fatty acids diet containing 5% w/w canola oil and 5% w/w omega 3 fatty acid supplement. The corn oil diet contains 0.1% omega 3 fatty 
acids and 6.1% omega 6 fatty acids, which is a relative ratio of omega 6 to omega 3 of 61: 1. The fish oil diet contains 3.65% omega 3 fatty acids and 
1.3% omega 6 fatty acids, which is a relative ratio of 1: 2.8.
aFrom: http://www.nal.usda.gov/fnic/foodcomp/search
bFrom: Manufacture's certified analyses.
Fish oil diets do not cause adverse reduction of white blood  cell counts in the peripheral blood Figure 3
Fish oil diets do not cause adverse reduction of white 
blood cell counts in the peripheral blood. White blood 
cell (WBC) counts in WBC/μl from female mice on the two 
diets until 115 days of age (n = 4 for fish oil, n = 5 for corn 
oil, p = 0.602). Error bars represent SEMs.Lipids in Health and Disease 2009, 8:9 http://www.lipidworld.com/content/8/1/9
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Diet
The base diet was an AIN-76A diet modified by substitu-
tion of 5% sucrose for 5% more oils to contain a total of
10% w/w oil (Tables 1 and 2). The fish oil diet contained
3.65% n-3 fatty acids and 1.3% n-6 fatty acids. The corn
oil diet contained 0.1% n-3 fatty acids and 6.1% n-6 fatty
acids. Diets were prepared in the Marshall University
School of Medicine animal diet prep room. Diet compo-
sition is shown in Table 1 and was formulated to be isoca-
loric, isonutrient and relevant to human consumption.
The AIN-76A diet is adequate for the nutritional support
of the mice[29]. The dry ingredients of the diet were
obtained in bulk from MP Biomedicals (Solon, Ohio),
sugar, corn and canola oil were purchased locally (100%
canola oil, 100% corn oil, no additives or preservatives).
The omega 3 supplement (OmegaRx Liquid) was pur-
chased from Zone Labs, Danvers, MA. Batches of diet were
prepared as needed, about every two weeks. The diet mix-
ture was pressed into trays and cut into small squares.
Individual cage sized portions (25–30 g) were stored in
sealed containers at -20°C to prevent oxidation of the fat
and bacterial growth in the food. Mice had free access to
food and water and were fed fresh food 5 days per week.
Food removed from cages was discarded.
Colony Forming Cell (CFC) Assays
FVB X sv129 F1hybrid mice were fed either a fish oil diet
(n = 5) or a corn oil diet (n = 5) from weaning until 60
days old. CFC assays were then performed upon bone
marrow isolated from these mice as previously dis-
cussed[30,31]. Briefly, bone marrow was harvested by
flushing from the femurs with Iscove's Modified Dul-
becco's Medium (IMDM) and cells were counted and
seeded in 4 well plates in at a density determined empiri-
cally by a pilot study conducted with a broad and consist-
ent range of seeding densities. After linear response of
colony production to seeding density was ensured by the
pilot study, seeding densities of 2.09 × 104 (fish oil) and
7.75 × 103 (corn oil) cells/well were chosen to produce
10–30 colonies for each well. Bone marrow was cultured
in 1% semi-solid Methocult M3434 (StemCell Technolo-
gies), supplemented with 0.4% autochthonous sera. Cells
were incubated for 6–7 days to allow colony formation.
Colonies with a minimum cell number of 20 were scored
as positive using an inverted microscope at 40× magnifi-
cation. Colonies were counted based on morphological
features that are associated with each progenitor type. Stu-
dent's t type tests were used to detect differences between
the experimental groups (n = 5).
White Blood Cell Counts
White blood cell counts were performed on EDTA antico-
agulated peripheral blood from tail veins of corn and fish
oil fed female mice aged 115 days. Fish and corn oil diets
were instituted after weaning. Student's t type tests were
used to detect differences between the experimental
groups.
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